Design, synthesis, characterization, antioxidant and in vitro cytotoxic activities of novel coumarin thiazole derivatives

Medicinal Chemistry Research

Volumn 24, Issue 3, 2015, Pages 1162-1169

  Thota, Sreekanth ^a   Nadipelly, Kavitha ^a   Shenkesi, Anusha ^a   Yerra, Rajeshwar ^a  

^a SR College of Pharmacy   (India)

Author keywords

Coumarin; Cytotoxic; DPPH

Indexed keywords

EID: 84939892110     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-014-1184-9     Document Type: Article

References (40)

1. Afsheen A, Hasnah O, Mark CB, Chan KL, Suriyati M, Anis SM (2011) Synthesis and antimicrobial properties of some new thiazolyl coumarin derivatives. Eur J Med Chem 46:3788-3794
2. Alvey L, Prado S, Huteau V, Saint-Joanis B, Michel S, Koch M, Cole ST, Tillequin F, Janin YL (2008) A new synthetic access to furo[3,2-f]chromene analogues of an antimycobacterial. Bioorg Med Chem 16:8264-8272
3. Bargagna A, Longobardi M, Mariani E, Schenone P (1990) 2H,5H-[1]benzothiopyrano [4, 3-b] pyran derivatives with platelet antiaggregating activity. IL Farmaco 45:405-413
4. Bargagna A, Longobardi M, Mariani E, Schenone P (1991) Benzo[6,7]cyclohepta[1,2-b]pyran derivatives with platelet antiaggregating and other activities. IL Farmaco 46:461-475
5. Bargagna A, Longobardi M, Mariani E, Schenone P (1992) Cyclohepta[b]pyran derivatives with platelet antiaggregating and other activities. IL Farmaco 47:345-355
6. Bianchi G, Tava A (1987) Synthesis of (2R)-(+)-2, 3-Dihydro-2, 6-dimethyl-4H-pyran-4-one, a homologue of pheromones of a species in the hepialidae family. Agric Biol Chem 51:2001-2002
7. Bruhlmann C, Ooms F, Carrupt P, Testa B, Catto M (2001) Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase. J Med Chem 44:3195-3198
8. Brunavs M, Dell CP, Gallagher PT, Owton WM (1993) European Pat Appl EP 557, 075. Chemical Abstracts (1994) 120 106786t
9. Burits M, Bucar F (2000) Antioxidant activity of Nigella sativa essential oil. Phytother Res 14:323-328
10. Christos AK, Dimitra JH (2004) Synthesis and biological evaluation of novel coumarin derivatives with a 7-azomethine linkage. Bioorg Med Chem Lett 14:611-614
11. Coudert P, Coyquelet JM, Bastide J, Marion Y, Fialip J (1988) Synthesis and anti-allergic properties of N-arylnitrones with furo-pyran structure. Ann Pharm Fr 46:91-96
12. Cuendet M, Hostettmann K, Potterat O (1997) Iridoid glucosides with free radical scavenging properties from Fagraea blumei. Helv Chim Acta 80:1144-1152
13. Eiden F, Denk F (1991) Synthesis of CNS-activity of pyran derivatives: 6,8-dioxabicyclo (3,2,1)octane. Arch Pharm Weinheim Ger 324:875-877
14. Ermili A, Roma G, Buonamici M, Cuttica A, Galante M (1979) Psychopharmacological study with K 8409, a 1H-naphtho[2,1-b]pyran 3-dialkylamino substituted derivative. II Farmaco 34:535-544
15. Gorlitzer K, Dehre A, Engler E (1984) Untersuchungen an 1,3-Dicarbonyl-Verbindungen, 22 Mitt. 3-Acyl-4-oxo-4H-[1] benzofuro[3, 2-b] pyrane. Arch Pharm Weinheim Ger 317:526-530
16. Green LC, Wagner DA, Glogowski J, Skipper PL (1982) Analysis of nitrate, nitrite, and [15 N]nitrate in biological fluids. Anal Biochem 126:131-138
17. Gursoy A, Karali N (2003) Synthesis, characterization and primary antituberculosis activity evaluation of 4-(3-Coumarinyl)-3-benzyl-4-thiazolin-2-one benzylidenehydrazones. Turk J Chem 27:545-552
18. Hiramoto K, Nasuhara A, Michiloshi K, Kato T, Kikugawa K (1997) DNA strand-breaking activity and mutagenicity of 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one (DDMP), a Maillard reaction product of glucose and glycine. Mutat Res 395:47-56
19. Horton DA, Bourne GT, Smythe ML (2003) The combinatorial synthesis of bicyclic privileged structures or privileged substructures. Chem Rev 103:893-930
20. Karki SS, Thota S, Satyanarayana YD (2007) Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds. Bioorg Med Chem 15:6632-6641
21. Kennedy RO, Thornes RD (1997) Coumarins: biology, applications and mode of action. Wiley, Chichester, pp 1-360
22. Kesten SR, Heffner TG, Johnson SJ, Pugsley TA (1999) Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists. J Med Chem 42:3718-3725
23. Liu J, Yi W (2008) 1-(1-Arylethylidene)thiosemicarbazide derivatives: a new class of tyrosinase inhibitors. Bioorg Med Chem 16:1096-1102
24. Longobardi M, Bargagna A, Mariani E, Schenone P (1990) 2H-[1]benzothiepino [5,4-b]pyran derivatives with local anesthetic and antiarrhythmic activities. IL Farmaco 45:399-404
25. Maeda M (1984) Laser Dyes. Academic, New York
26. Mahantesha B, Vishwanath BJ, Nivedita NB, Sandeep SL, Venkatesh DN (2014) Synthesis, structure-activity relationship of iodinated-4-aryloxymethyl-coumarins as potential anti-cancer and anti-mycobacterial agents. Eur J Med Chem 74:225-233
27. Marcocci L, Maguire JJ, Droy-Lefaix MT (1994) The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem Biophys Res Commun 201:748-755
28. Martinez AG, Marco LJ (1997) Friedländer reaction on 2-amino-3-cyano-4H-pyrans: Synthesis of derivatives of 4H-pyran [2,3-b] quinoline, new tacrine analogues. Bioorg Med Chem Lett 7:3165-3170
29. Mohr SJ, Chirigos MA, Fuhrman FS, Pryer JW (1975) Pyran copolymer as an effective adjuvant to chemotherapy against a murine leukemia and solid tumor. Cancer Res 35:3750-3754
30. Narender T, Gupta S (2009) A convenient and biogenetic type synthesis of few naturally occurring chromenodihydrochalcones and their in vitro antileishmanial activity. Bioorg Med Chem Lett 14:3913-3916
31. Narender T, Gupta S, Gorlitzer K, Dehre A (1983) 2-(1H-Tetrazol-5-yl)-4,5-dihydro-4-oxo-indeno[1,2-b] pyran. Arch Pharm Weinheim Ger 316:264-270
32. Nermien MS, Hany MM, Shymaa SM, Ahmed ME (2011) Synthesis of 4H-chromene, coumarin 12H-chromeno[2,3-d]pyrimidine derivatives and some of their antimicrobial and cytotoxicity activities. Eur J Med Chem 46:765-772
33. Ruch RJ, Cheng SJ, Klaunig JE (1989) Prevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from Chinese green tea. Carcinogenesis 10:1003-1008
34. Smith WP, Sollis LS, Howes D, Cherry CP, Starkey DI (1998) Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides. J Med Chem 41:787-797
35. Tandon VK, Vaish M, Jain S, Bhakuni DS, Srimal (1991) Synthesis carbon-13 NMR and hypotensive action of 2,3-dihydro-2,2-dimethyl-4H-naphtho [1,2-b] pyran-4-one. Indian J Pharm Sci 53:22-23
36. Taylor RN, Cleasby A, Singh O, Sharzynski T, Wonacott JA, Smith WP, Sollis LS, Howes DP, Cherry CP, Bethell R, Colman P (1998) Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4h-pyran-6-carboxamides and sialidase from influenza virus types A and B. J Med Chem 41:798-807
37. Thota S, Imran M, Udugula M, Yerra R (2012) Synthesis, spectroscopic characterization and in vitro antitumor activities of some novel mononuclear Ru(II) complexes. Chin Chem Lett 23:466-469
38. Zabradnik M, Procházka Ž (1992) The production and application of fluorescent brightening agents. Wiley, New York
39. Zamocka J, Misikova E, Durinda J (1992) Cesk-Farm (Ceska a Slovenska Farmacie) 41, 170. Chem Abstr 116:106031q
40. Zhang Y, Zou B, Chen Z, Pan Y, Wang H, Liang H, Yi X (2011) Synthesis and antioxidant activities of novel 4-Schiff base-7-benzyloxy-coumarin derivatives. Bioorg Med Chem Lett 21:6811-6815